The European Society for Hemapheresis - short ESFH - was founded in 1984 with the aim of gathering European physicians, scientists, and allied health personnel working in the field of Hemapheresis with a vision to improve donor and patient care. The mission of ESFH is to advance knowledge in apheresis techniques through education, to consolidate and spread proven methods, and to open new paths in the collection of blood cells and treatment of diseases by apheresis.

Learn More

From the literature:

UPDATE  ESFH 21st  Congress    2021,  May 26th - 27th  Digital  PROGRAM
    Presentations  and Session Videos

H. Vrielink Convalescent Plasma: from whom and when (pdf) 
Video
 Hans Vrielink  MD PhD: Convalescent plasma: from whom and when
M.Lozano  Apheresis techniques in the treatment of severe COVID-19 patients (pdf)
Video:Miquel Lozano: Apheresis techniques in the treatment of severe COVID-19 patients
L.Pierelli  Clinical impact of allogeneic stem cells cryopreservation during COVID-19 pandemic(pdf)
Video  Luca Pierell:
Clinical impact of allogeneic stem cells cryopreservation during COVID-19 pandemic
M.-J Mustieles:Vascular Aaccess: Always Central Line?  (pdf)
Video  M.J. Mustieles
:Vascular Aaccess: Always Central Line?
Video Marie Scully:
New treatment strategies in management of TTP

WAA  WEBINAR  September 15, 2021, 12:00 pm -2:00pm (EST)
Role of Apheresis in Cellular Therapies and Thrombosis Following COVID- 19
To register please go to: https://us02web.zoom.us/webinar/register/WN_61FziquaSTGXv7uj0R1DiQ

Webinars produced  by  Terumo BCT with the collaboration of ESFH
 On-Demand WebinarOne Year In: Lessons Learned About Transfusion of Convalescent Plasma (CP) for COVID-19
Register Now                     Presented by
Dr. Miquel Lozano, Chief, Hemotherapy Section, Hospital Clinic de Barcelona, Spain
Dr. Claudia Cohn, Chief Medical Officer, AABB
Dr. Leandro Burgos Pratx, Executive Chief of the Service of Transfusion Medicine, Hospital Italiano of Buenos Aires, Brazil
Dr. Silvano Wendel, Medical Director, Hospital Sirio Libanes São Paulo,
Brazil
Deirdre Fehily, PhD, Policy Officer – Substances of Human Origin Team, European Commission             

Recently an interesting investigation was published in Vox Sanguinis concerning in vitro evaluation of buffy coat derived granulocytes for the...
In this paper, the group from Pamplona shows data of stem cell mobilization with filgrastim (G-CSF) in 36 healthy family donors, of which 18...
In this paper the authors reviewed more than 50.000 extracorporeal procedures in 7.142 patients regarding incidence and severity of apheresis...